Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...
Mobile Pathways, a leading tech nonprofit ensuring fair access to justice for immigrants, has successfully raised $1 million ...
The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback